Nucleic Acid Isolation Market Worth $3,106.28 Million by 2018 - New Research Report by MarketsandMarkets

Share Article

The technological advancements and the increased government support in the form of funding are the factors that drive the nucleic acid isolation and purification market across the globe -



Bio-Rad Laboratories Inc. (U.S.), Danaher Corporation (U.S.), Illumina Inc. (U.S.), Life Technologies (U.S.), Promega Corporation (U.S.), Qiagen (Netherlands), Roche Applied Sciences (Germany), and Thermo Fisher Scientific Inc. (U.S.)

The “Nucleic Acid Isolation and Purification Market by Technology (Column based, Reagent based, Magnetic bead based), Consumables & Instruments, by Application (Plasmid DNA isolation, MIRNA isolation, Total RNA isolation), End users - Global Forecasts to 2018” provides a detailed overview of the major drivers, restraints, challenges, opportunities, current market trends, and strategies impacting the global nucleic acid isolation and purification market along with the estimates and forecasts of the revenue and share analysis.

This report studies the global nucleic acid isolation market over the forecast period of 2013 to 2018. This market is valued at an estimated $2,103.39 million in 2013.

For Further Inquiry:

The report segments this market by technology, application, product, end user, and geography. The technology segments included in this report are column-based, magnetic bead-based, reagent-based, and other (anion exchange-based, glass fiber-based) for DNA and RNA isolation and purification. Of these, the column-based technology for DNA isolation and purification commands the largest share of the global market and is also poised to grow at the healthy CAGR between 2013 and 2018. However, magnetic bead-based technology for DNA isolation will grow at highest CAGR during the forecasted period. Use of purified form of DNA in research for various downstream processes is the primary growth driver of this technology segment.

The nucleic acid isolation and purification market is rapidly getting highly consolidated. For instance, in February 2014, Thermo Fisher Scientific acquired Life Technologies Corporations (U.S.), which strengthened its portfolio of reagents, consumables, instruments, and systems. In 2013, the top five players had a combined market share of over 90%. This makes it difficult for new players to differentiate their technology platforms and penetrate the market. Furthermore, there is a large variation in technology preference in different geographic and application segments. Low-cost reagent-based techniques for nucleic acid isolation and purification are still being preferred over kits and instrument-based techniques in key geographic segments of Asia and Latin America. Reagent-based techniques are also being preferred for specific applications like genomic DNA isolation. With such substantial difference in user preference for technologies and applications, it becomes important for market players to identify current market size and future market potential for each technology and application segment. This information will enable market players to make well-informed decisions about growth strategies in this highly competitive and evolved market.

Request for customization of report @

The global nucleic acid isolation and purification industry presents significant growth potential. Most players in this market are aiming to either diversify their product portfolios or expand their geographic presence to maintain their market shares. Between 2011 and 2013, entering into collaborative partnerships was an important growth strategy adopted by most players in the nucleic acid isolation and purification market.

This strategy was employed by players to gain immediate technological competency and widen their geographic presence. For instance in July 2013, QIAGEN partnered with Exosome Diagnostics Inc. (U.S.) to develop and commercialize high-performance sample preparation kits for the processing of nucleic acids from exosomes. This strategy was mainly adopted by Illumina, Inc. (U.S.), GE Healthcare (U.K.), Life Technologies (U.S.), QIAGEN (Netherlands), and Roche Applied Sciences (Germany).

Browse Related Reports:
Isothermal Nucleic Acid Amplification Technology (INAAT) Market by Application (Infectious Diseases, Blood Screening, Research), Products (Instruments, Reagents), End-User (Hospital, Reference Laboratories, Other) - Global Forecast to 2018

Dairy Herd Management Market by Product (Hardware, Systems & Software), Application (Feeding, Milking, Heat Stress, Animal Comfort, & Reproduction Management) & by End User (Small, Large & Cooperative Dairy Farms) - Global Forecast to 2018

About MarketsandMarkets
MarketsandMarkets is a global market research and consulting company based in the U.S. We publish strategically analyzed market research reports and serve as a business intelligence partner to Fortune 500 companies across the world.

MarketsandMarkets also provides multi-client reports, company profiles, databases, and custom research services. MarketsandMarkets covers thirteen industry verticals, including advanced materials, automotive and transportation, banking and financial services, biotechnology, chemicals, consumer goods, energy and power, food and beverages, industrial automation, medical devices, pharmaceuticals, semiconductor and electronics, and telecommunications and IT.

We at MarketsandMarkets are inspired to help our clients grow by providing apt business insight with our huge market intelligence repository.

Mr. Rohan
North - Dominion Plaza,
17304,Preston Road,
Suite 800, Dallas, TX 75252
Tel: +1-888-600-6441
Email: sales(at)marketsandmarkets(dot)com
Visit MarketsandMarkets Blog @
Connect with us on LinkedIn @

Share article on social media or email:

View article via:

Pdf Print

Contact Author

Mr. Rohan
Market Research Report
since: 12/2010
Like >
Visit website